180 related articles for article (PubMed ID: 27010533)
1. Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer.
Koukourakis MI; Kakouratos C; Kalamida D; Bampali Z; Mavropoulou S; Sivridis E; Giatromanolaki A
Int J Radiat Biol; 2016 Jul; 92(7):353-63. PubMed ID: 27010533
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis.
Giatromanolaki A; Gkegka AG; Pouliliou S; Biziota E; Kakolyris S; Koukourakis M
Breast Cancer Res Treat; 2022 Jul; 194(1):13-23. PubMed ID: 35482128
[TBL] [Abstract][Full Text] [Related]
3. Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy.
Koukourakis MI; Giatromanolaki A; Winter S; Leek R; Sivridis E; Harris AL
Oncology; 2009; 77(5):285-92. PubMed ID: 19923867
[TBL] [Abstract][Full Text] [Related]
4. Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer.
Koukourakis MI; Giatromanolaki A; Simopoulos C; Polychronidis A; Sivridis E
Clin Exp Metastasis; 2005; 22(1):25-30. PubMed ID: 16132575
[TBL] [Abstract][Full Text] [Related]
5. Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy.
Koukourakis MI; Giatromanolaki A; Panteliadou M; Pouliliou SE; Chondrou PS; Mavropoulou S; Sivridis E
Br J Cancer; 2014 Apr; 110(9):2217-23. PubMed ID: 24714743
[TBL] [Abstract][Full Text] [Related]
6. Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
Andersen S; Eilertsen M; Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
Lung Cancer; 2011 Jun; 72(3):294-302. PubMed ID: 21075472
[TBL] [Abstract][Full Text] [Related]
7. ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder.
Keymoosi H; Gheytanchi E; Asgari M; Shariftabrizi A; Madjd Z
Asian Pac J Cancer Prev; 2014; 15(5):2013-20. PubMed ID: 24716927
[TBL] [Abstract][Full Text] [Related]
8. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
[TBL] [Abstract][Full Text] [Related]
9. Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer.
Koukourakis MI; Giatromanolaki A; Polychronidis A; Simopoulos C; Gatter KC; Harris AL; Sivridis E
Cancer Sci; 2006 Jul; 97(7):582-8. PubMed ID: 16827797
[TBL] [Abstract][Full Text] [Related]
10. LDH-A promotes malignant progression via activation of epithelial-to-mesenchymal transition and conferring stemness in muscle-invasive bladder cancer.
Jiang F; Ma S; Xue Y; Hou J; Zhang Y
Biochem Biophys Res Commun; 2016 Jan; 469(4):985-92. PubMed ID: 26721441
[TBL] [Abstract][Full Text] [Related]
11. Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases.
Koukourakis MI; Kontomanolis E; Giatromanolaki A; Sivridis E; Liberis V
Gynecol Obstet Invest; 2009; 67(3):162-8. PubMed ID: 19088479
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia inducible factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy.
Koukourakis MI; Giatromanolaki A; Danielidis V; Sivridis E
Int J Radiat Biol; 2008 Jan; 84(1):47-52. PubMed ID: 17852557
[TBL] [Abstract][Full Text] [Related]
13. Characterization of CD44+ALDH1+Ki-67- Cells in Non-malignant and Neoplastic Lesions of the Breast.
DA Cruz Paula A; Marques O; Sampaio R; Rosa A; Garcia J; Rêma A; DE Fátima Faria M; Silva P; Vizcaíno R; Lopes C
Anticancer Res; 2016 Sep; 36(9):4629-38. PubMed ID: 27630305
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer.
Xu N; Shao MM; Zhang HT; Jin MS; Dong Y; Ou RJ; Wang HM; Shi AP
Cancer Epidemiol; 2015 Jun; 39(3):375-81. PubMed ID: 25843691
[TBL] [Abstract][Full Text] [Related]
15. Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins.
Giatromanolaki A; Koukourakis MI; Pezzella F; Sivridis E; Turley H; Harris AL; Gatter KC
Leuk Lymphoma; 2008 Nov; 49(11):2181-6. PubMed ID: 19021062
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA.
Hu D; Linders A; Yamak A; Correia C; Kijlstra JD; Garakani A; Xiao L; Milan DJ; van der Meer P; Serra M; Alves PM; Domian IJ
Circ Res; 2018 Oct; 123(9):1066-1079. PubMed ID: 30355156
[TBL] [Abstract][Full Text] [Related]
17. Warburg effect, lactate dehydrogenase, and radio/chemo-therapy efficacy.
Koukourakis MI; Giatromanolaki A
Int J Radiat Biol; 2019 Apr; 95(4):408-426. PubMed ID: 29913092
[TBL] [Abstract][Full Text] [Related]
18. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA
Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy.
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Trarbach T; Folprecht G; Shi MM; Lebwohl D; Jalava T; Laurent D; Meinhardt G; Harris AL
Clin Cancer Res; 2011 Jul; 17(14):4892-900. PubMed ID: 21632858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
